Related Experiment Video
Updated: Jul 4, 2026
10:17
An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
Published on: November 3, 2010
Comparison of two-phase analyses for case-control genetic association studies
Gang Zheng1, Mark Meyer, Wentian Li
1Office of Biostatistics Research, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA. zhengg@nhlbi.nih.gov
Statistics in Medicine
|June 24, 2008
Summary
This study introduces a new two-phase analysis for genetic association studies, comparing it with existing methods. Some two-phase analyses demonstrate greater power than traditional tests when the significance level in phase 1 is appropriately chosen.
Area of Science:
- Genetics
- Biostatistics
- Epidemiology
Background:
- Case-control studies commonly use genotype-based tests like Cochran-Armitage trend tests (CATTs) and Pearson's chi-square test to assess genetic association with complex diseases.
- Previous work introduced the Hardy-Weinberg disequilibrium trend test, which was combined with CATT for association testing.
- Single-phase analysis uses one statistic, while two-phase analysis employs two statistics within a single framework, utilizing all case-control data.
Purpose of the Study:
- To investigate a novel two-phase analysis procedure for genetic association testing in case-control studies.
- To compare the performance of three distinct two-phase analysis procedures against common single-phase methods through extensive simulations.
- To apply the findings to real-world data from two case-control studies for practical illustration.
Main Methods:
- Extensive simulation studies were conducted to evaluate the statistical power of different association testing strategies.
- The study focused on two-phase analysis procedures, which utilize two test statistics and are robust to moderate departures from Hardy-Weinberg equilibrium (HWE).
- The performance of the new two-phase procedure was compared with existing two-phase and single-phase methods.
Main Results:
- The simulation studies provided a comprehensive comparison of the statistical power of single-phase and various two-phase analysis procedures.
- The results indicated that certain two-phase analyses can achieve higher statistical power compared to commonly used single-phase tests.
- The effectiveness of two-phase analyses is contingent upon the appropriate selection of the significance level for the initial phase of analysis.
Conclusions:
- Two-phase analysis represents a promising strategy for detecting genetic associations in case-control studies.
- With careful selection of the phase 1 significance level, some two-phase analyses can offer superior power over traditional single-phase tests.
- The findings have implications for optimizing genetic association study designs and analysis strategies.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Test for Homogeneity
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...
02:46Chi-square Analysis
The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...